Tibet Cheezheng Tibetan Medicine Co., Ltd.
SZSE:002287.SZ
24.08 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 2,010.313 | 2,044.789 | 1,770.486 | 1,476.214 | 1,402.677 | 1,213.209 | 1,053.151 | 968.354 | 994.728 | 950.106 | 969.467 | 934.275 | 789.225 | 523.645 | 469.298 | 413.48 | 339.273 | 267.916 |
Cost of Revenue
| 382.417 | 324.14 | 265.342 | 206.733 | 180.298 | 147.957 | 133.124 | 150.032 | 201.047 | 250.052 | 356.379 | 436.587 | 359.252 | 135.926 | 97.248 | 70.634 | 63.279 | 56.75 |
Gross Profit
| 1,627.896 | 1,720.65 | 1,505.143 | 1,269.481 | 1,222.379 | 1,065.253 | 920.027 | 818.322 | 793.68 | 700.054 | 613.087 | 497.688 | 429.973 | 387.719 | 372.05 | 342.847 | 275.995 | 211.166 |
Gross Profit Ratio
| 0.81 | 0.841 | 0.85 | 0.86 | 0.871 | 0.878 | 0.874 | 0.845 | 0.798 | 0.737 | 0.632 | 0.533 | 0.545 | 0.74 | 0.793 | 0.829 | 0.813 | 0.788 |
Reseach & Development Expenses
| 50.539 | 55.094 | 70.823 | 60.324 | 55.549 | 36.814 | 25.763 | 28.895 | 30.545 | 31.262 | 25.447 | 17.296 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 55.294 | 47.674 | 43.236 | 33.844 | 55.185 | 21.236 | 18.001 | 22.979 | 26.99 | 23.491 | 29.678 | 24.063 | 52.763 | 49.914 | 39.021 | 33.95 | 30.65 | 16.988 |
Selling & Marketing Expenses
| 977.775 | 938.168 | 842.709 | 714.903 | 699.718 | 629.986 | 517.507 | 462.967 | 410.079 | 353.435 | 281.705 | 217.779 | 183.952 | 186.481 | 184.808 | 177.864 | 151.073 | 100.51 |
SG&A
| 1,111.921 | 985.841 | 885.945 | 748.747 | 754.903 | 651.222 | 535.508 | 485.947 | 437.069 | 376.927 | 311.383 | 241.842 | 236.715 | 236.395 | 223.83 | 211.814 | 181.723 | 117.498 |
Other Expenses
| 0.844 | 77.981 | 50.515 | 37.528 | 43.493 | -3.714 | 2.369 | 38.467 | 18.307 | 53.295 | 38.435 | 15.851 | 7.676 | 19.885 | 13.352 | 3.754 | 8.752 | 7.199 |
Operating Expenses
| 1,161.616 | 1,118.916 | 1,007.283 | 846.599 | 853.946 | 744.523 | 605.585 | 566.603 | 542.715 | 465.196 | 388.882 | 298.451 | 245.754 | 243.482 | 231.773 | 218.189 | 187.373 | 121.874 |
Operating Income
| 466.28 | 521.541 | 790.206 | 457.279 | 401.529 | 354.046 | 321.663 | 275.315 | 273.086 | 232.912 | 219.711 | 207.009 | 195.304 | 154.103 | 149.786 | 133.437 | 109.078 | 97.278 |
Operating Income Ratio
| 0.232 | 0.255 | 0.446 | 0.31 | 0.286 | 0.292 | 0.305 | 0.284 | 0.275 | 0.245 | 0.227 | 0.222 | 0.247 | 0.294 | 0.319 | 0.323 | 0.322 | 0.363 |
Total Other Income Expenses Net
| 176.245 | -2.339 | -2.292 | -10.577 | -0.27 | 29.603 | 9.59 | 62.043 | 40.405 | 51.206 | 33.695 | 23.61 | 18.724 | 29.691 | 22.389 | 12.481 | 28.931 | 15.13 |
Income Before Tax
| 642.525 | 519.202 | 787.914 | 446.702 | 401.259 | 350.333 | 324.032 | 313.763 | 291.371 | 286.064 | 257.9 | 222.847 | 202.943 | 173.928 | 162.666 | 137.138 | 117.553 | 104.422 |
Income Before Tax Ratio
| 0.32 | 0.254 | 0.445 | 0.303 | 0.286 | 0.289 | 0.308 | 0.324 | 0.293 | 0.301 | 0.266 | 0.239 | 0.257 | 0.332 | 0.347 | 0.332 | 0.346 | 0.39 |
Income Tax Expense
| 65.235 | 49.694 | 77.088 | 40.785 | 36.869 | 32.891 | 23.26 | 25.977 | 30.014 | 50.595 | 46.735 | 35.047 | 32.293 | 3.338 | 1.482 | 1.186 | 1.622 | 0.071 |
Net Income
| 581.199 | 472.542 | 715.876 | 403.961 | 364.254 | 318.767 | 300.842 | 289.862 | 264.911 | 237.534 | 213.373 | 190.179 | 170.718 | 170.461 | 160.812 | 135.795 | 115.84 | 105.95 |
Net Income Ratio
| 0.289 | 0.231 | 0.404 | 0.274 | 0.26 | 0.263 | 0.286 | 0.299 | 0.266 | 0.25 | 0.22 | 0.204 | 0.216 | 0.326 | 0.343 | 0.328 | 0.341 | 0.395 |
EPS
| 1.1 | 0.89 | 1.35 | 0.76 | 0.69 | 0.6 | 0.57 | 0.55 | 0.5 | 0.45 | 0.41 | 0.36 | 0.32 | 0.32 | 0.32 | 0.28 | 0.25 | 2.04 |
EPS Diluted
| 1.1 | 0.89 | 1.35 | 0.76 | 0.69 | 0.6 | 0.57 | 0.55 | 0.5 | 0.45 | 0.41 | 0.36 | 0.32 | 0.32 | 0.32 | 0.28 | 0.25 | 2.04 |
EBITDA
| 562.052 | 665.432 | 901.244 | 510.35 | 435.33 | 380.446 | 358.358 | 350.055 | 330.668 | 268.233 | 264.096 | 217.752 | 196.401 | 183.418 | 151.008 | 146.314 | 128.464 | 95.592 |
EBITDA Ratio
| 0.28 | 0.325 | 0.509 | 0.346 | 0.31 | 0.314 | 0.34 | 0.361 | 0.332 | 0.282 | 0.272 | 0.233 | 0.249 | 0.35 | 0.322 | 0.354 | 0.379 | 0.357 |